204 related articles for article (PubMed ID: 10385263)
1. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.
Watson N; Daniels DV; Ford AP; Eglen RM; Hegde SS
Br J Pharmacol; 1999 May; 127(2):590-6. PubMed ID: 10385263
[TBL] [Abstract][Full Text] [Related]
2. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
[TBL] [Abstract][Full Text] [Related]
3. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
[TBL] [Abstract][Full Text] [Related]
4. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of muscarinic receptors implicated in rabbit detrusor muscle contraction and activation of inositol phospholipid hydrolysis in rabbit detrusor and parotid gland.
Barras M; Coste A; Eon MT; Guillot E
Fundam Clin Pharmacol; 1999; 13(5):562-70. PubMed ID: 10520729
[TBL] [Abstract][Full Text] [Related]
6. Tolterodine--a new bladder-selective antimuscarinic agent.
Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
[TBL] [Abstract][Full Text] [Related]
7. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the muscarinic receptor subtype mediating contraction of human peripheral airways.
Watson N; Magnussen H; Rabe KF
J Pharmacol Exp Ther; 1995 Sep; 274(3):1293-7. PubMed ID: 7562501
[TBL] [Abstract][Full Text] [Related]
9. Histamine H1 receptor down-regulation mediated by M3 muscarinic acetylcholine receptor subtype.
Miyoshi K; Kawakami N; Wakayama Y; Izumi N; Horio S; Fukui H
J Pharmacol Sci; 2004 Aug; 95(4):426-34. PubMed ID: 15286428
[TBL] [Abstract][Full Text] [Related]
10. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
Olianas MC; Maullu C; Onali P
Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
[TBL] [Abstract][Full Text] [Related]
11. Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland.
Moriya H; Takagi Y; Nakanishi T; Hayashi M; Tani T; Hirotsu I
Life Sci; 1999; 64(25):2351-8. PubMed ID: 10374898
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
[TBL] [Abstract][Full Text] [Related]
13. M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro.
Sellers DJ; Yamanishi T; Chapple CR; Couldwell C; Yasuda K; Chess-Williams R
J Auton Pharmacol; 2000 Jun; 20(3):171-6. PubMed ID: 11193006
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle.
Choppin A; Eglen RM
Br J Pharmacol; 2001 Feb; 132(4):835-42. PubMed ID: 11181424
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors.
Smith CM; Wallis RM
J Recept Signal Transduct Res; 1997; 17(1-3):177-84. PubMed ID: 9029489
[TBL] [Abstract][Full Text] [Related]
16. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase.
Wotta DR; Wattenberg EV; Langason RB; el-Fakahany EE
Pharmacology; 1998 Apr; 56(4):175-86. PubMed ID: 9566019
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Gillberg PG; Sundquist S; Nilvebrant L
Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptor M3 mediates human gallbladder contraction through voltage-gated Ca2+ channels and Rho kinase.
Lee MC; Yang YC; Chen YC; Huang SC
Scand J Gastroenterol; 2013 Feb; 48(2):205-12. PubMed ID: 23227858
[TBL] [Abstract][Full Text] [Related]
19. Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists.
Richards MH; van Giersbergen PL
Br J Pharmacol; 1995 Mar; 114(6):1241-9. PubMed ID: 7620715
[TBL] [Abstract][Full Text] [Related]
20. Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.
Moro C; Uchiyama J; Chess-Williams R
Urology; 2011 Dec; 78(6):1442.e9-15. PubMed ID: 22001099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
